US Patent Issued to ENTEROME on Oct. 21 for "Immunogenic compounds for cancer therapy" (French, American Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,201, issued on Oct. 21, was assigned to ENTEROME S.A. (Paris).

"Immunogenic compounds for cancer therapy" was invented by Laurent Chene (Neuville Aux Bois, France), Alban Mathieu (Saint Foy les Lyon, France) and Matthieu Pichaud (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification."

The...